NCT00318630View on ClinicalTrials.gov

The Effect Of AVANDIA On The Late Asthmatic Response

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

July 22, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Asthma

Interventions

DRUG

Rosiglitazone

Rosiglitazone will be given as immediate release tablet of 4 milligrams administered orally for 28 days.

DRUG

Placebo

Subjects will also receive placebo oral tablet.

Trial Locations (1)

6035

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY